Tackling antimicrobial resistance at global and local scales

Trends in Microbiology

Volumn 23, Issue 9, 2015, Pages 524-526

  Gelband, Hellen ^a   Laxminarayan, Ramanan ^a  

^a Center for Energy Economics and Policy Resources for the Future   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ DERIVATIVE; CHLOROQUINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; AWARENESS; BLOOD CULTURE; DRUG COST; DRUG EFFICACY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; MALARIA FALCIPARUM; MEDICAL DOCUMENTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; RAPID TEST; RISK REDUCTION; CLIMATE CHANGE; HEALTH; LEGISLATION AND JURISPRUDENCE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLIMATE CHANGE; DRUG RESISTANCE, MICROBIAL; GLOBAL HEALTH; HEALTH POLICY; HUMANS;

EID: 84940388794     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2015.06.005     Document Type: Note

References (13)

1. Laxminarayan R., et al. Antibiotic resistance - the need for global solutions. Lancet Infect. Dis. 2013, 13:1057-1098.
2. Van Boeckel T.P., et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 2014, 14:1-9.
3. Global Strategy for Containment of Antimicrobial Resistance 2001, World Health Organization, Geneva.
4. Braykov N.P., et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect. Dis. 2014, 14:1220-1227.
5. Laxminarayan R., Gelband H. A global subsidy: key to affordable drugs for malaria?. Health Aff. (Millwood) 2009, 28:949-961.
6. Arrow K.J., et al. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance 2004, National Academies Press.
7. Tougher S., et al. Effect of the Affordable Medicines Facility - malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet 2012, 6736:1-11.
8. Gelband H. The global antibiotic resistance partnership. AMR Control 2015: Confronting Antimicrobial Resistance 2015, 98-101. Global Health Dynamics. J. Carlet, G. Upham (Eds.).
9. Mendelson M., Matsoso M.P. A global call for action to combat antimicrobial resistance: can we get it right this time?. S. Afr. Med. J. 2014, 104:478-479.
10. Nga D.T.T., et al. Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study. BMC Pharmacol. Toxicol. 2014, 15:6.
11. Van T.D., et al. Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baumannii complex strains isolated from a referral hospital in northern Vietnam. J. Global Antimicrob. Resist. 2014, 2:318-321.
12. Wertheim H., et al. Global survey of polymyxin use: a call for international guidelines. J. Global Antimicrob. Resist. 2013, 1:131-134.
13. Van Kinh N., et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health 2013, 13:1158.